163 related articles for article (PubMed ID: 8845385)
1. Stable MLV-VL30 dicistronic retroviral vectors with a VL30 or MoMLV sequence promoting both packaging of genomic RNA and expression of the 3' cistron.
Torrent C; Berlioz C; Darlix JL
Hum Gene Ther; 1996 Mar; 7(5):603-12. PubMed ID: 8845385
[TBL] [Abstract][Full Text] [Related]
2. An internal ribosomal entry signal in the rat VL30 region of the Harvey murine sarcoma virus leader and its use in dicistronic retroviral vectors.
Berlioz C; Torrent C; Darlix JL
J Virol; 1995 Oct; 69(10):6400-7. PubMed ID: 7666541
[TBL] [Abstract][Full Text] [Related]
3. Characterization of an internal ribosomal entry segment within the 5' leader of avian reticuloendotheliosis virus type A RNA and development of novel MLV-REV-based retroviral vectors.
López-Lastra M; Gabus C; Darlix JL
Hum Gene Ther; 1997 Nov; 8(16):1855-65. PubMed ID: 9382952
[TBL] [Abstract][Full Text] [Related]
4. Identification of an internal ribosome entry segment in the 5' region of the mouse VL30 retrotransposon and its use in the development of retroviral vectors.
López-Lastra M; Ulrici S; Gabus C; Darlix JL
J Virol; 1999 Oct; 73(10):8393-402. PubMed ID: 10482590
[TBL] [Abstract][Full Text] [Related]
5. A small and efficient dimerization/packaging signal of rat VL30 RNA and its use in murine leukemia virus-VL30-derived vectors for gene transfer.
Torrent C; Gabus C; Darlix JL
J Virol; 1994 Feb; 68(2):661-7. PubMed ID: 8289369
[TBL] [Abstract][Full Text] [Related]
6. Efficient packaging of a specific VL30 retroelement by psi 2 cells which produce MoMLV recombinant retroviruses.
Hatzoglou M; Hodgson CP; Mularo F; Hanson RW
Hum Gene Ther; 1990; 1(4):385-97. PubMed ID: 1964095
[TBL] [Abstract][Full Text] [Related]
7. Use and comparison of different internal ribosomal entry sites (IRES) in tricistronic retroviral vectors.
Douin V; Bornes S; Creancier L; Rochaix P; Favre G; Prats AC; Couderc B
BMC Biotechnol; 2004 Jul; 4():16. PubMed ID: 15279677
[TBL] [Abstract][Full Text] [Related]
8. Retroviral vectors containing putative internal ribosome entry sites: development of a polycistronic gene transfer system and applications to human gene therapy.
Morgan RA; Couture L; Elroy-Stein O; Ragheb J; Moss B; Anderson WF
Nucleic Acids Res; 1992 Mar; 20(6):1293-9. PubMed ID: 1313966
[TBL] [Abstract][Full Text] [Related]
9. An internal ribosomal entry mechanism promotes translation of murine leukemia virus gag polyprotein precursors.
Berlioz C; Darlix JL
J Virol; 1995 Apr; 69(4):2214-22. PubMed ID: 7884868
[TBL] [Abstract][Full Text] [Related]
10. Analytical study of rat retrotransposon VL30 RNA dimerization in vitro and packaging in murine leukemia virus.
Torrent C; Bordet T; Darlix JL
J Mol Biol; 1994 Jul; 240(5):434-44. PubMed ID: 8046749
[TBL] [Abstract][Full Text] [Related]
11. A murine leukemia virus derived retroviral vector with a rat VL30 packaging psi sequence.
Torrent C; Wang P; Darlix JL
Bone Marrow Transplant; 1992; 9 Suppl 1():143-7. PubMed ID: 1324044
[TBL] [Abstract][Full Text] [Related]
12. Retroviral vectors containing chimeric promoter/enhancer elements exhibit cell-type-specific gene expression.
Couture LA; Mullen CA; Morgan RA
Hum Gene Ther; 1994 Jun; 5(6):667-77. PubMed ID: 7948129
[TBL] [Abstract][Full Text] [Related]
13. Analysis of the relative level of gene expression from different retroviral vectors used for gene therapy.
Byun J; Kim SH; Kim JM; Yu SS; Robbins PD; Yim J; Kim S
Gene Ther; 1996 Sep; 3(9):780-8. PubMed ID: 8875226
[TBL] [Abstract][Full Text] [Related]
14. Construction of new retroviral producer cells from adenoviral and retroviral vectors.
Lin X
Gene Ther; 1998 Sep; 5(9):1251-8. PubMed ID: 9930327
[TBL] [Abstract][Full Text] [Related]
15. The selectable marker neo gene down-regulates gene expression from retroviral vectors containing an internal ribosome entry site.
Byun J; Kim JM; Robbins PD; Kim S
Gene Ther; 1998 Oct; 5(10):1441-4. PubMed ID: 9930351
[TBL] [Abstract][Full Text] [Related]
16. Versatile retroviral vectors for potential use in gene therapy.
Hawley RG; Lieu FH; Fong AZ; Hawley TS
Gene Ther; 1994 Mar; 1(2):136-8. PubMed ID: 7584069
[TBL] [Abstract][Full Text] [Related]
17. A spleen necrosis virus-based retroviral vector which expresses two genes from a dicistronic mRNA.
Koo HM; Brown AM; Kaufman RJ; Prorock CM; Ron Y; Dougherty JP
Virology; 1992 Feb; 186(2):669-75. PubMed ID: 1310190
[TBL] [Abstract][Full Text] [Related]
18. Transmission of endogenous VL30 retrotransposons by helper cells used in gene therapy.
Chakraborty AK; Zink MA; Hodgson CP
Cancer Gene Ther; 1994 Jun; 1(2):113-8. PubMed ID: 7621242
[TBL] [Abstract][Full Text] [Related]
19. Construction of adenoviral and retroviral vectors coexpressing the genes encoding the hepatitis B surface antigen and B7-1 protein.
He XS; Rivkina M; Robinson WS
Gene; 1996 Oct; 175(1-2):121-5. PubMed ID: 8917087
[TBL] [Abstract][Full Text] [Related]
20. Packaging of endogenous retroviral sequences in retroviral vectors produced by murine and human packaging cells.
Patience C; Takeuchi Y; Cosset FL; Weiss RA
J Virol; 1998 Apr; 72(4):2671-6. PubMed ID: 9525584
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
